PubMed: Aspartame: Should individuals with Type II Diabetes be taking it

Here you will find all the discussions from the time this group was hosted on YahooGroups and groups.io
You can browse through these topics and reply to them as needed.
It is not possible to start new topics in this forum. Please use the respective other forums most related to your topic.
Post Reply
Soroush Ebrahimi
Moderator
Posts: 4510
Joined: Thu Feb 07, 2002 11:00 pm

PubMed: Aspartame: Should individuals with Type II Diabetes be taking it

Post by Soroush Ebrahimi »

The answer is NO! Please see below.
If you need more information on Aspartame, please contact myself or Betty Martini.
Soroush
From: Dr. Betty Martini,D.Hum. [mailto:bettym19@mindspring.com]
Sent: Monday, June 5, 2017 10:37 PM
To: bettym19@mindspring.com
Subject: PubMed: Aspartame: Should individuals with Type II Diabetes be taking it
* Aspartame simulates and aggravates diabetic retinopathy and neuropathy, destroys the optic nerve, causes diabetics to go into convulsions and interacts with insulin. The methanol cause them to lose limbs. Written by the late world expert on aspartame, H. J. Roberts, M.D., in "Aspartame Disease: An Ignored Epidemic" , 1000 page medical text. www.amazon.com , diabetic specialist
Dr. Betty Martini, D.Hum, Dounswe
MiSSion Possible World Health Intl
www.mpwhi.om
Also on aspartame, www.wnho.net , www.holistixmed.oaspartame and www.holiixmed.comaspaeeteame . www.ampartame kills com
My NCBI Sign in to NCBI Sign Out
PubMed
US National Library of Medicine National Institutes of Health
Create File
See comment in PubMed Commons below
Curr Diabetes Rev. 2017 May 31. doi: 10.2174/1573399813666170601093336. [Epub ahead of print]
Aspartame: should individuals with Type II Diabetes be taking it?
Choudhary AK 1.
Author information
1

Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria. South Africa.
Abstract
BACKGROUND:
Individuals with type II diabetes (T2D) have to manage blood glucose levels to sustain health and longevity. Artificial sweeteners (including aspartame) are suggested sugar alternatives for these individuals. The safety of aspartame in particular, has long been the centre of debate. Although it is such a controversial product, many clinicians recommend its use to T2D patients, during a controlled diet and as part of an intervention strategy. Aspartame is 200 times sweeter than sugar and has a negligible effect on blood glucose levels, and it is suggested for use so that T2D can control carbohydrate intake and blood glucose levels. However, research suggests that aspartame intake may lead to an increased risk of weight gain rather than weight loss, and cause impaired blood glucose tolerance in T2D.
OBJECTIVE:
This review consolidates knowledge gained from studies that link aspartame consumption to the various mechanisms associated with T2D.
METHOD:
We review literature that provides evidence that raise concerns that aspartame may exacerbate T2D and add to the global burden of disease.
RESULT:
Aspartame may act as a chemical stressor by increasing cortisol levels, and may induce systemic oxidative stress by producing excess free radicals, and it may also alter gut microbial activity and interfere with the N-methyl D-aspartate (NMDA) receptor, resulting in insulin deficiency or resistance.
CONCLUSION:
Aspartame and its metabolites are safe for T2D is still debatable due to a lack of consistent data. More research is required that provides evidence and raise concerns that aspartame may exacerbate prevalence of pathological physiology in the already stressed physiology of T2D.

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org .
KEYWORDS:
Aspartame; glucose; insulin; type II diabetes; weight gainPMID:

28571543

DOI:

10.2174/1573399813666170601093336

* Share on Facebook
* Share on Twitter
* Share on Google+

PubMed Commons home
PubMed Commons
0 comments
How to join PubMed Commons
How to cite this comment:
Supplemental Content
Save items
Add to Favorites View more options

* Create collection...
* Manage collections...

loading
Similar articles
* Neurophysiological symptoms and aspartame: What is the connection? [Nutr Neurosci. 2017]
* Neurophysiological symptoms and aspartame: What is the connection?
* Choudhary AK, Lee YY. Nutr Neurosci. 2017 Feb 15; :1-11. Epub 2017 Feb 15.
* Differential effects of early-life NMDA receptor antagonism on aspartame-impaired insulin tolerance and behavior. [Physiol Behav. 2016]
* Differential effects of early-life NMDA receptor antagonism on aspartame-impaired insulin tolerance and behavior.
* Collison KS, Inglis A, Shibin S, Andres B, Ubungen R, Thiam J, Mata P, Al-Mohanna FA. Physiol Behav. 2016 Dec 1; 167:209-221. Epub 2016 Sep 15.
* Effects of three intense sweeteners on fat storage in the C. elegans model. [Chem Biol Interact. 2014]
* Effects of three intense sweeteners on fat storage in the C. elegans model.
* Zheng J, Greenway FL, Heymsfield SB, Johnson WD, King JF, King MJ, Gao C, Chu YF, Finley JW. Chem Biol Interact. 2014 May 25; 215:1-6. Epub 2014 Mar 13.
* Review Sugar consumption, metabolic disease and obesity: The state of the controversy. [Crit Rev Clin Lab Sci. 2016]
* Review Sugar consumption, metabolic disease and obesity: The state of the controversy.
* Stanhope KL. Crit Rev Clin Lab Sci. 2016; 53(1):52-67. Epub 2015 Sep 17.
* Review Artificial sweeteners: safe or unsafe? [J Pak Med Assoc. 2015]
* Review Artificial sweeteners: safe or unsafe?
* Qurrat-ul-Ain, Khan SA. J Pak Med Assoc. 2015 Feb; 65(2):225-7.

See reviews... See all...
Recent Activity
ClearTurn OffTurn On

* Aspartame: should individuals with Type II Diabetes be taking it?
* Aspartame: should individuals with Type II Diabetes be taking it?
* Curr Diabetes Rev. 2017 May 31. doi: 10.2174/1573399813666170601093336. [Epub ahead of print] PubMed
* aspartame and oxidative excess (2)
* PubMed
* aspaertame and oxidative excess (4505)
* PubMed
* Neurophysiological symptoms and aspartame: What is the connection?
* Neurophysiological symptoms and aspartame: What is the connection?
* Nutr Neurosci. 2017 Feb 15:1-11. doi: 10.1080/1028415X.2017.1288340. [Epub ahead of print] PubMed
* Aspartame and oxidative stress (27)
* PubMed
Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on
See more...
You are here: NCBI > Literature > PubMed
Support Center

National Center for Biotechnology Information , U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD, 20894 USA
Policies and Guidelines | Contact
Preferences Turn off
External link. Please review our privacy policy .
Share

* Share on Facebook
* Share on Twitter
* Share on Google+

URL

Loading ...


Post Reply

Return to “Minutus YahooGroup Archives”